Delivery Order 36F79718D0524-36C24823N0381
Award Date
2/5/23
Potential Completion Date
2/4/24
Potential Value
$133K
Federal Agency
Veterans Integrated Service Network 8
Awardee
Veracyte, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 8 (VISN 8), a component of the U.S. Department of Veterans Affairs, to Veracyte, Inc. for molecular thyroid testing services. The contract has a total ceiling value of $484,800.00 and a period of performance through August 31, 2029. Veracyte is a for-profit organization that provides genomic testing services, including for cancer screening and diagnosis, to federal agencies. This award is part...
This firm fixed-price purchase order was awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs to Veracyte, Inc., a for-profit provider of genomic testing services, to conduct referral laboratory testing for thyroid genomic expression classifier (GEC) testing. The $202,552.00 contract has a period of performance through September 30, 2024. Veracyte has provided similar genomic testing services to support cancer detection and diagnosis for...
This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 16 (VISN 16), part of the U.S. Department of Veterans Affairs, to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for thyroid testing services, with a ceiling value of $165,200.00 and a period of performance through April 30, 2026. Veracyte has provided similar laboratory testing services to the Department of Defense and Veterans Affairs in the past, using...
This firm fixed-price purchase order was awarded by the Veterans Health Administration's Veterans Integrated Service Network 17 (VISN 17) to Veracyte, Inc., a for-profit corporation that provides genomic testing services. The $512,000.00 contract will support cancer detection and diagnosis efforts for VISN 17 facilities through August 2027. Veracyte will provide genomic classifier laboratory testing to analyze gene expression patterns in biopsy samples, aiding in the diagnosis and treatment of...
This federal contract award to Veracyte, Inc. provides for thyroid tissue testing services to support cancer detection efforts at Department of Veterans Affairs (VA) medical facilities. The firm fixed price contract, valued at $93,648.69, was issued under the VA's Medical Laboratory Testing and Analysis Services (FSS-621-II) schedule contract. It has an ultimate completion date of September 30, 2020. Veracyte, a for-profit organization, has provided similar genomic testing services to the...
This is a Delivery Order awarded to Veracyte, Inc., a for-profit organization, by the Veterans Integrated Service Network 16 (VISN 16) of the Department of Veterans Affairs. The contract has a ceiling value of $19,392.00 and is for a Thyroid Testing Task Order to be performed in Jackson, MS. The contract is a Firm Fixed Price with Economic Price Adjustment and does not have a set-aside designation. Veracyte previously held an Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle with...
Veracyte, Inc. was awarded a $96,960 delivery order for gene testing services from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. The firm fixed price order is associated with the Medical Laboratory Testing and Analysis Services Government-Wide Acquisition Contract and has a completion date of February 4, 2025. Veracyte will provide the genomic classifier laboratory testing at its facility located in South San Francisco, California to...
This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 23 (VISN 23) to Veracyte, Inc., a for-profit company that provides genomic testing services. The contract is a Delivery Order valued at $484,428.50 for "FARGO THYROID BIOPSY TESTING" services. The contract is a Firm Fixed Price agreement with no set-aside designation, and it runs through September 30, 2019. Veracyte holds an Indefinite...
The U.S. Department of Veterans Affairs (VA) awarded a $77,295.91 firm fixed price delivery order contract to Veracyte, Inc., a for-profit organization, to provide the AFIRMA Thyroid Genomic Classifier (GEC) test. This test analyzes gene expression patterns in thyroid biopsy samples to aid in diagnosis and treatment planning. The contract was issued without a set-aside and has a period of performance through November 4, 2022. Veracyte has also been awarded an Indefinite Delivery Indefinite...
This firm fixed-price purchase order for $77,700 was awarded by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for Afirma Gene Expression Classifier and Atlas Expression Classifier testing, which analyze gene expression patterns in thyroid biopsy samples to determine malignancy risk and aid in diagnosis and treatment decisions for veterans. This award is not set...